Effectiveness of Invasive Electrostimulation Combined With an Exercise Program in Plantar Fasciitis

N/ACompletedNCT03020693

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal60 enrolled

Overview

This study evaluates the effectiveness of an electrostimulation treatment with TENS using a needle and a surface electrode combined with an exercise program to fasciitis plantar. Half participants will receive invasive electrostimulation (TENS using a needle) and exercises while the other half will receive electrostimulation placebo and exercises.

There are a lot of treatments to fasciitis plantar. Exercises are the treatments more recommended to fasciitis plantar but not all patients improve only with exercises. Dry needling is recommended to relieve the pain in the heel. TENS is used to decrease the pain in the fasciitis plantar. Investigators will apply to half participants a treatment that combines TENS + Dry needling (invasive electrostimulation ) with exercises while the other half receive electrostimulation placebo (TENS using surface electrodes with non-therapeutic intensity) + exercises.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Fasciitis, Plantar

Interventions

Invasive electrostimulation combined with exercisesPROCEDURE

Procedure for producing analgesia by introducing the TENS current through a needle combined with a exercises program.

Placebo electrostimulation and exercisesPROCEDURE

First: Sham dry needling. After: electrostimulation using surfaces electrodes. Finally a exercises program.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Medical diagnosis of plantar fasciitis * Age equal or superior to 18 years old. * VAS minimum of 2 points int the first steps after a prolonged decreasing period. * Having an evolution of a month or more of pain. * Not having received acupuncture or dry needling as treatment. Exclusion Criteria: * Peripheral Neuropathies. * Tarsus tunnel syndrome. * Rheumatic diseases. * Contraindication to dry needling: nickel allergy, fear of needles, sky with erosions. * Clotting disorders such as thrombosis or thrombophlebitis. * Fractures, infections and/ or tumor processes. * Have been treated for plantar fasciitis in the las 4 weeks. * Previous surgery in the foot * Pregnancy. * Communication Disorders. * Holders of pacemakers or electrostimulators.

Locations (1)

Fundacion Hospital Ramón y Cajal

Madrid, Spain

Outcomes

Primary Outcomes

Change from baseline in pain scores on the visual analogue scale at 6 weeks in patients with plantar fasciitis.

It will evaluate the pain with Visual Analogue Scale in the first step in the first and tenth session. At 6 weeks, a new measurement will be made.

Time frame: 6 weeks

Secondary Outcomes

Change in strength scores at 6 weeks from first session in patients with plantar fasciitis.

It will evaluate the strength using dynamometer in the first and tenth session. At 6 weeks, a new measurement will be made.

Time frame: 6 weeks

Change in the pain in the Trigger points at 6 weeks from first session in patients with plantar fasciitis.

It will evaluate the pain with algometer in the first and tenth session in the plantar muscle. It will measure the change of pain in the Trigger points in the plantar muscle. At 6 weeks, a new measurement will be made .Three measurements will be made and the average data will be recorded.

Time frame: 6 weeks

Change in the functionality of foot and ankle at 6 weeks from first session in patients with plantar fasciitis.

It will evaluate the functionality using Foot and Ankle Ability Measure questionnaire (FAAM) in the first and tenth session. At 6 weeks, a new measurement will be made.

Time frame: 6 weeks

Change in the functionality and quality of life of foot and ankle at 6 weeks from first session in patients with plantar fasciitis.

It will evaluate the functionality and quality of life using Foot Health Status Questionnaire (FHSQ) in the first and tenth session. At 6 weeks, a new measurement will be made.

Time frame: 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.